Deaths from malaria in sub-Saharan Africa could return to levels last seen 20 years ago because of severe […]

In the hunt for a COVID-19 therapy, some researchers have hit upon a combination of antimalarial hydroxychloroquine and […]

Pharma companies are a popular target for politicians, activists and critics in general. But with the world in dire […]

Critics of covid-19 management say that something should have been done weeks before it was,1 forgetting that most […]

Safety of new treatments for multiple sclerosisImmunomodulating treatments help people with multiple sclerosis by reducing relapse rate and […]

The reason I write this letter is to take a small step towards helping readers with evidence based […]

Two thirds of healthcare workers who have died from covid-19 were from an ethnic minority background, and at […]

The Indian government has given an ordinance that makes violence against healthcare workers a non-bailable offence, punishable by […]

REACH2 is the first Phase III study in steroid-refractory acute graft-versus-host-disease (GvHD) to have met its primary endpoint

The decision ensures that the merger between Mylan and Upjohn does not harm competition